June 21, 2025 a 06:00 pm
IDXX: Fundamental Ratio Analysis - IDEXX Laboratories, Inc.
IDEXX Laboratories is a prominent leader in veterinary diagnostics and water testing solutions. The company's robust market penetration in various diagnostics markets positions it for steady future growth. Despite some financial challenges, the overall outlook remains optimistic for the long term.
Fundamental Rating
IDEXX maintains a solid fundamental rating, showing strength in cash flow and equity returns while facing challenges with debt and valuations.
| Category | Score | Progress |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
Recent evaluations indicate a stable overall score with consistent cash flow predictions and equity returns.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-20 | 3 | 3 | 5 | 5 | 1 | 1 | 1 |
| Previous Date | 3 | 3 | 5 | 5 | 1 | 1 | 1 |
Analyst Price Targets
Analyst estimates reflect a bullish outlook with high expectations for stock performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| 600 | 247 | 536.5 | 479.75 |
Analyst Sentiment
The current analyst ratings suggest confidence with a strong buy bias.
| Recommendation | Number of Ratings | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 11 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
IDEXX Laboratories demonstrates reliable market performance with strengths in equity and asset returns, though it faces challenges with its debt profile. The stock's future growth is supported by a positive analyst sentiment and substantial price targets. Investors should consider potential valuation risks, but overall, the company's diversified presence and innovation in diagnostics provide promising opportunities. Caution is due with variability in market dynamics, yet IDEXX remains a compelling prospect in the diagnostics sector.